Dare Bioscience (DARE) Reports In-Line Q2 EPS

Dare Bioscience (NASDAQ: DARE) reported Q2 EPS of ($0.10), in-line with the analyst estimate of ($0.10).

For earnings history and earnings-related data on Dare Bioscience (DARE) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• RBC Capital Downgrades Bucher Industries AG (BUCN:SW) (BCHHF) to Sector Perform
• Isabella Bank added to Russell 2000 index after Nasdaq listing